Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 8/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | SCN5A | Q14524 | 3/20 | 0.43 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.43 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.40 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.38 |
| ▸ | FEN1 | P39748 | 1/20 | 0.38 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1712531 | 0.80 | CYP1A2 (0.47) | KIF11CYP1A2CYP2C19 | |
| SCHEMBL1712450 | 0.80 | CYP1A2 (0.47) | KIF11CYP1A2CYP2C19 | |
| SCHEMBL1712451 | 0.80 | CYP1A2 (0.47) | KIF11CYP1A2CYP2C19 | |
| Hydrochloric Acid SCHEMBL8064648 | 0.78 | CYP1A2 (0.46) | KIF11CYP1A2CYP2C19 | |
| SCHEMBL11796507 | 0.77 | KIF11 (0.47) | KIF11PKMSCN5ASCN9APARP1 | |
| SCHEMBL28403655 | 0.77 | POLB (0.42) | KIF11PKMSCN5ASCN9AGRM2 | |
| SCHEMBL28403656 | 0.77 | POLB (0.42) | KIF11PKMSCN5ASCN9AGRM2 | |
| SCHEMBL25399741 | 0.76 | PKM (0.64) | KIF11PKMSCN5ASCN9APARP1 | |
| SCHEMBL19731492 | 0.75 | CYP19A1 (0.45) | KIF11SCN5ASCN9APARP1 | |
| SCHEMBL8898972 | 0.75 | KIF11 (0.49) | KIF11GRM2GRM3CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114901274-A | Improved methods, kits, compositions and dosing regimens using heterocyclic inhibitors of ERK1 and ERK2 | 阿沙纳生物科学公司 | 2022-08-12 | — | — | CN | disclosed |